See also this year's filing and all EDGAR filings for this company.
PDF Report 0000944809_2021_OPKO_Health_INC.pdf
Logs
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 1.7855733987079463, 'aggregate_val': 1395316000, 'exp_sum': 500908000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 355573000, 'ResearchAndDevelopmentExpense': 75316000, 'remainder_Expenses': 70019000}} |
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 2.063410593449693, 'aggregate_val': 1771457000, 'exp_sum': 578263000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 468857000, 'ResearchAndDevelopmentExpense': 76850000, 'remainder_Expenses': 32556000}} |
Graph
Absolute values for 0000944809, OPKO Health INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 523,179,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,155,604,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 794,280,000 |
| 4 | LiabilitiesCurrent | 375,483,000 |
| 5 | LiabilitiesNoncurrent | 426,029,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 362,306,499 |
| 9 | ResearchAndDevelopmentExpense | -70,737,270 |
| 10 | remainder_Expenses | 969,879,127 |
| 11 | remainder_Revenues | 1,572,912,928 |
| 12 | remainder_NetIncome | -15,806,190 |
| 13 | remainder_ComprehensiveNetIncome | 11,235,202 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,473,063,000 |
| 1 | Liabilities | 801,512,000 |
| 2 | Expenses | 1,261,448,356 |
| 3 | Revenues | 1,572,912,928 |
| 4 | StockholdersEquity | 1,671,551,000 |
| 5 | NetIncome | 295,658,382 |
| 6 | ComprehensiveNetIncome | 301,275,983 |
| 7 | BaseVar | 3,067,988,838 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.41 |
| 9 | EconomicCapitalRatio | 3.30 |
Edgar->Model Mapping
Feature Distribution
Change over Time
